Voya Investment Management LLC lowered its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 7.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,669 shares of the medical equipment provider's stock after selling 2,250 shares during the quarter. Voya Investment Management LLC's holdings in STERIS were worth $5,893,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of STE. Avalon Trust Co bought a new stake in shares of STERIS in the fourth quarter valued at about $30,000. Human Investing LLC bought a new stake in shares of STERIS in the 4th quarter valued at about $31,000. Anfield Capital Management LLC lifted its position in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division raised its position in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after acquiring an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC boosted its holdings in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after buying an additional 137 shares in the last quarter. Institutional investors own 94.69% of the company's stock.
STERIS Stock Performance
Shares of STE traded down $0.13 during trading hours on Tuesday, hitting $224.17. The stock had a trading volume of 113,743 shares, compared to its average volume of 537,968. The firm has a 50-day moving average price of $223.14 and a 200 day moving average price of $218.76. STERIS plc has a fifty-two week low of $200.98 and a fifty-two week high of $248.24. The firm has a market capitalization of $22.02 billion, a price-to-earnings ratio of 47.56 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.
STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, research analysts anticipate that STERIS plc will post 9.08 EPS for the current year.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on STE shares. Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a research report on Monday, April 7th. Stephens reissued an "overweight" rating and set a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. Piper Sandler lifted their target price on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Finally, JMP Securities reiterated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, April 10th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $258.75.
Check Out Our Latest Analysis on STE
STERIS Company Profile
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Articles

Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.